483 Document: Granules Pharmaceuticals Inc., Jan 28, 2022

FDANews 483 Granules Pharmaceuticals Inc. Jan 28 2022 top
William J. Leonard FDA Investigator Roseline N. Boateng FDA Investigator

On Jan 28, 2022, the FDA inspected Granules Pharmaceuticals Inc.'s Chantilly site. Explore the inspectional observations.